免疫公司
DE ˙ DB
€16.63 ↓ -16.55 (-49.87%)
2019-04-18
分享價格
SecurityDE:10V / Immunic, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership964,230 shares
Latest Disclosed Value $ 1,070,295
BlackRock, Inc. reports 34.39% increase in ownership of 10V / Immunic, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 964,230 shares of Immunic, Inc. (DE:10V) valued at $1,070,295 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 717,470 shares of Immunic, Inc.. This represents a change in shares of 34.39% during the quarter. The current value of the position is $16,037,073 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F IMMUNIC COM 4525EP101 964,230 246,760 34.39 1,070 180.10 0.0000
2026-02-12 2025-12-31 13F IMMUNIC COM 4525EP101 717,470 -8,273 -1.14 383 -40.22 0.0000
2025-11-12 2025-09-30 13F IMMUNIC COM 4525EP101 725,743 27,004 3.86 640 31.21 0.0000
2025-08-12 2025-06-30 13F IMMUNIC COM 4525EP101 698,739 -58,389 -7.71 487 -40.97 0.0000
2025-05-02 2025-03-31 13F IMMUNIC COM 4525EP101 757,128 -27,085 -3.45 825 5.23 0.0000
2025-02-07 2024-12-31 13F IMMUNIC COM 4525EP101 784,213 99,550 14.54 784 -30.56 0.0000
2024-11-13 2024-09-30 13F IMMUNIC COM 4525EP101 684,663 5,320 0.78 1,130 49.73 0.0000
2024-08-13 2024-06-30 13F IMMUNIC COM 4525EP101 679,343 18,089 2.74 754 -13.53 0.0000
2024-05-10 2024-03-31 13F IMMUNIC COM 4525EP101 661,254 299,128 82.60 873 60.59 0.0000
2024-02-13 2023-12-31 13F IMMUNIC COM 4525EP101 362,126 5,317 1.49 543 3.63 0.0000
2023-11-13 2023-09-30 13F IMMUNIC COM 4525EP101 356,809 -20,694 -5.48 525 -44.67 0.0000
2023-08-11 2023-06-30 13F IMMUNIC COM 4525EP101 377,503 9,061 2.46 948 72.81 0.0000
2023-05-12 2023-03-31 13F IMMUNIC COM 4525EP101 368,442 1,703 0.46 549 6.82 0.0000
2023-02-13 2022-12-31 13F IMMUNIC COM 4525EP101 366,739 -99,798 -21.39 513 -65.22 0.0000
2022-11-14 2022-09-30 13F IMMUNIC COM 4525EP101 466,537 -5,114 -1.08 1,475 -9.84 0.0001
2022-08-12 2022-06-30 13F IMMUNIC COM 4525EP101 471,651 -842,833 -64.12 1,636 -88.99 0.0001
2022-05-12 2022-03-31 13F IMMUNIC COM 4525EP101 1,314,484 11,708 0.90 14,853 19.14 0.0004
2022-02-10 2021-12-31 13F IMMUNIC COM 4525EP101 1,302,776 51,631 4.13 12,467 12.59 0.0003
2021-11-09 2021-09-30 13F IMMUNIC COM 4525EP101 1,251,145 124,852 11.09 11,073 -19.81 0.0003
2021-08-11 2021-06-30 13F IMMUNIC COM 4525EP101 1,126,293 391,501 53.28 13,808 17.90 0.0004
2021-05-07 2021-03-31 13F IMMUNIC COM 4525EP101 734,792 15,671 2.18 11,712 6.52 0.0003
2021-02-05 2020-12-31 13F IMMUNIC COM 4525EP101 719,121 217,897 43.47 10,995 18.14 0.0004
2020-11-06 2020-09-30 13F IMMUNIC COM 4525EP101 501,224 292,185 139.78 9,307 267.28 0.0003
2020-08-14 2020-06-30 13F IMMUNIC COM 4525EP101 209,039 176,621 544.82 2,534 1,199.49 0.0001
2020-05-01 2020-03-31 13F IMMUNIC COM 4525EP101 32,418 -1,583 -4.66 195 -40.91 0.0000
2020-02-13 2019-12-31 13F IMMUNIC COM 4525EP101 34,001 8,815 35.00 330 31.47 0.0000
2019-11-08 2019-09-30 13F IMMUNIC COM 4525EP101 25,186 12,585 99.87 251 73.10 0.0000
2019-08-22 2019-06-30 13F/A-1 IMMUNIC COM 4525EP101 12,601 -1,779,217 -99.30 145 -58.92 0.0000
2019-08-13 2019-06-30 13F IMMUNIC COM 4525EP101 12,601 145
2019-05-09 2019-03-31 13F VITAL THERAPIES COM 92847R104 1,791,818 -75,631 -4.05 353 1.44 0.0000
2019-02-08 2018-12-31 13F VITAL THERAPIES COM 92847R104 1,867,449 -488,603 -20.74 348 -46.38 0.0000
2018-11-09 2018-09-30 13F VITAL THERAPIES COM 92847R104 2,356,052 114,027 5.09 649 -95.77 0.0000
2018-08-09 2018-06-30 13F VITAL THERAPIES COM 92847R104 2,242,025 1,287,310 134.84 15,356 136.57 0.0007
2018-05-09 2018-03-31 13F VITAL THERAPIES COM 92847R104 954,715 -36,113 -3.64 6,491 10.09 0.0003
2018-02-09 2017-12-31 13F VITAL THERAPIES COM 92847R104 990,828 571,418 136.24 5,896 178.38 0.0003
2017-11-14 2017-09-30 13F VITAL THERAPIES COM 92847R104 419,410 34,359 8.92 2,118 89.78 0.0001
2017-08-10 2017-06-30 13F VITAL THERAPIES COM 92847R104 385,051 -975,722 -71.70 1,116 -79.50 0.0001
2017-05-12 2017-03-31 13F VITAL THERAPIES COM 92847R104 1,360,773 1,359,431 101,298.88 5,444 90,633.33 0.0003
2017-02-10 2016-12-31 13F VITAL THERAPIES COM 92847R104 1,342 -258 -16.12 6 -33.33 0.0000
2016-11-08 2016-09-30 13F VITAL THERAPIES COM 92847R104 1,600 0 0.00 9 0.00 0.0000
2016-08-10 2016-06-30 13F VITAL THERAPIES COM 92847R104 1,600 386 31.80 9 -18.18 0.0000
2016-05-10 2016-03-31 13F VITAL THERAPIES COM 92847R104 1,214 817 205.79 11 120.00 0.0000
2016-02-11 2015-12-31 13F VITAL THERAPIES COM 92847R104 397 0 0.00 5 150.00 0.0000
2015-11-13 2015-09-30 13F VITAL THERAPIES COM 92847R104 397 0 0.00 2 -75.00 0.0000
2015-08-07 2015-06-30 13F VITAL THERAPIES COM 92847R104 397 251 171.92 8 100.00 0.0000
2015-05-13 2015-03-31 13F VITAL THERAPIES COM 92847R104 146 146 4 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.